NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · USD

Pasithea Therapeutics Corp. (KTTAW) Stock Analysis

Pasithea Therapeutics Corp. (KTTAW) is a stock listed on NASDAQ and quoted in US Dollar.

KTTAW

$0.01

+$0.00 (+103.70%)

Sep 2, 2026 · Market close

This is a derivative instrument — a warrant on Pasithea Therapeutics Corp. (KTTA) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View KTTA →

Price History

Hover for the daily close. The dotted line marks the period open.

KTTAW Key Statistics

As of Sep 2, 2026
Trading
Open
$0.01
Previous Close
$0.00
Day's Range
0.00–0.01
52-Week Range
0.00–0.01
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.29

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

KTTAW Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−75.45%
2025 (partial year)+0.00%

As of September 2, 2026.

Recent News

News provided by third-party sources. Not financial advice.

About Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumor; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Visit website →